US 8021644
Methods for measuring rates of reverse cholesterol transport in vivo, as an index of anti-atherogenesis
granted A61KA61K49/0004A61K51/04
Quick answer
US patent 8021644 (Methods for measuring rates of reverse cholesterol transport in vivo, as an index of anti-atherogenesis) held by The Regents of the University of California expires Mon Sep 15 2031 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Regents of the University of California
- Grant date
- Tue Sep 20 2011 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Sep 15 2031 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 4
- CPC classes
- A61K, A61K49/0004, A61K51/04, A61K51/0493, A61K51/1224